TMC207: Promising new drug for tuberculosis
Submitted by Bobby Ramakant (bobby) about 1 year ago
Addition of the new drug, TMC207 to standard multidrug-resistant TB (MDR-TB) treatment regimens dramatically cuts the period from when patients start treatment to their sputum testing negative for TB. This new drug, TMC207 is being developed by a pharmaceutical research company, Tibotec, in collaboration with TB Alliance. Read source article...
Keywords: drug resistance extensively drug-resistant M/XDR-TB MDR-TB multi-drug resistant research TB TMC207 tuberculosis XDR-TB
West Africa
1 comments
Mail a friend
Edit
Mail a friend
You need to be logged in for this page.
Comments 
204 johni about 1 year ago
Thats good to hear! Lets hope that it has been tested and its use has got no any effect to humanity. Big up to scientists
Login to submit comments.
History for this post
You need to log in to see posts' history.
Vote history
Positive votes
